| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 16 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Foods and drinks | |
| #4 | Measurement | |
| #5 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Enzymes | |
| #4 | Microorganisms | |
| #5 | Peptides | |
| #6 | Syringes | |
| #7 | Analysing materials | |
| #8 | Fermentation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hartman Jacob | 9 |
| #2 | Mendelovitz Simona | 9 |
| #3 | Lamoreaux Brian | 9 |
| #4 | Kent Jeffrey D | 5 |
| #5 | Kent Jeffrey | 4 |
| #6 | Rosario-Jansen Theresa | 4 |
| #7 | Wright David Erick | 4 |
| #8 | Fischer Meir | 2 |
| #9 | Harosh Eliyahu | 2 |
| #10 | Saifer Mark G P | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021042055A1 | Pegloticase for treatment of gout in renal transplant recipients | |
| WO2020160324A1 | Reducing immunogenicity to pegloticase | |
| WO2020160325A1 | Reducing immunogenicity to pegloticase | |
| US2020237879A1 | Tolerization reduces intolerance to pegloticase and prolongs the urate lowering effect (triple) | |
| CN110234340A | Prednisone and the combination treatment of uric acid enzyme molecule and application thereof |